Prevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietin
dc.authorid | DEMIR, Mehmet/0000-0001-5942-3751 | |
dc.authorwosid | DEMIR, Mehmet/AAH-2121-2019 | |
dc.contributor.author | Hoppensteadt, DA | |
dc.contributor.author | Tobu, M | |
dc.contributor.author | Chatha, M | |
dc.contributor.author | Bansal, V | |
dc.contributor.author | Moghaddam, M | |
dc.contributor.author | Saxena, R | |
dc.contributor.author | Ahmad, S | |
dc.date.accessioned | 2024-06-12T11:23:55Z | |
dc.date.available | 2024-06-12T11:23:55Z | |
dc.date.issued | 2004 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | 56th Annual Meeting of the American-Association-for-Clinical-Chemistry -- JUL 25-29, 2004 -- Los Angeles, CA | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Assoc Clin Chem | en_US |
dc.identifier.endpage | A54 | en_US |
dc.identifier.issn | 0009-9147 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | A54 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/26706 | |
dc.identifier.volume | 50 | en_US |
dc.identifier.wos | WOS:000221955200174 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Assoc Clinical Chemistry | en_US |
dc.relation.ispartof | Clinical Chemistry | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Prevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietin | en_US |
dc.type | Conference Object | en_US |